Attana AB announced that a collaborative research agreement had been signed with one of the leading US academic medical centers within biomedical research, focusing on viruses and antibodies. Since then, Attana has installed an Attana Cell[TM] 250 instrument, trained laboratory personnel, and provided application support services. On June 23, 2022 the parties have agreed to extend the collaboration into October.

As previously communicated, this agreement may be mutually extended until the end of 2025.